{"id":"https://openalex.org/W1978196659","doi":"https://doi.org/10.1177/026988110401800411","title":"Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans","display_name":"Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans","alternate_titles":[],"publication_year":2004,"publication_date":"2004-12-01","ids":{"openalex":"https://openalex.org/W1978196659","doi":"https://doi.org/10.1177/026988110401800411","mag":"1978196659","pmid":"https://pubmed.ncbi.nlm.nih.gov/15582920"},"language":"en","primary_location":{"id":"doi:10.1177/026988110401800411","doi":"https://doi.org/10.1177/026988110401800411","is_oa":false,"landing_page_url":"https://doi.org/10.1177/026988110401800411","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1978196659"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071583939","display_name":"William Walton Stoops","orcid":"https://orcid.org/0000-0002-8502-0160","observed_orcids":["https://orcid.org/0000-0002-8502-0160"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"William W. Stoops","raw_affiliation_strings":["Departments of Behavioral Science, College of Medicine, and Psychology, University of Kentucky, Lexington, KY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Behavioral Science, College of Medicine, and Psychology, University of Kentucky, Lexington, KY, USA","institution_ids":["https://openalex.org/I143302722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003807463","display_name":"Paul E.A. Glaser","orcid":"https://orcid.org/0000-0001-6387-7035","observed_orcids":["https://orcid.org/0000-0001-6387-7035"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul E.A. Glaser","raw_affiliation_strings":["Departments of Psychiatry and Anatomy and Neurobiology, College of Medicine, University of Kentucky, Lexington, KY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Psychiatry and Anatomy and Neurobiology, College of Medicine, University of Kentucky, Lexington, KY, USA","institution_ids":["https://openalex.org/I143302722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047202317","display_name":"Mark T. Fillmore","orcid":"https://orcid.org/0000-0003-2889-5726","observed_orcids":["https://orcid.org/0000-0003-2889-5726"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark T. Fillmore","raw_affiliation_strings":["Department of Psychology, University of Kentucky, Lexington, KY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychology, University of Kentucky, Lexington, KY, USA","institution_ids":["https://openalex.org/I143302722"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036283865","display_name":"Craig R. Rush","orcid":"https://orcid.org/0000-0002-0814-8558","observed_orcids":["https://orcid.org/0000-0002-0814-8558"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Craig R. Rush","raw_affiliation_strings":["Departments of Behavioral Science and Psychiatry, College of Medicine, and Psychology, University of Kentucky, Lexington, KY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Behavioral Science and Psychiatry, College of Medicine, and Psychology, University of Kentucky, Lexington, KY, USA","institution_ids":["https://openalex.org/I143302722"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5036283865"],"corresponding_institution_ids":["https://openalex.org/I143302722"],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":1.5255,"has_fulltext":false,"cited_by_count":80,"citation_normalized_percentile":{"value":0.78294263,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"18","issue":"4","first_page":"534","last_page":"543"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.8988999724388123,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.8988999724388123,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.06960000097751617,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.00930000003427267,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/methylphenidate","display_name":"methylphenidate","score":1.0},{"id":"https://openalex.org/keywords/d-amphetamine","display_name":"d-amphetamine","score":0.9850000143051147},{"id":"https://openalex.org/keywords/drug-self-administration","display_name":"self-administration","score":0.8569999933242798},{"id":"https://openalex.org/keywords/reinforcing-effects","display_name":"reinforcement effect","score":0.671999990940094},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.6240000128746033},{"id":"https://openalex.org/keywords/performance-effects","display_name":"performance effects","score":0.7760000228881836},{"id":"https://openalex.org/keywords/physiological-effects","display_name":"physiological effects","score":0.9330000281333923},{"id":"https://openalex.org/keywords/cocaine-like-effects","display_name":"cocaine-like effects","score":0.4429999887943268},{"id":"https://openalex.org/keywords/stimulant-misuse","display_name":"stimulant abuse","score":0.42100000381469727}],"concepts":[{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.9749495983123779},{"id":"https://openalex.org/C2777193897","wikidata":"https://www.wikidata.org/wiki/Q179452","display_name":"Amphetamine","level":3,"score":0.8735920190811157},{"id":"https://openalex.org/C2780557958","wikidata":"https://www.wikidata.org/wiki/Q211036","display_name":"Stimulant","level":2,"score":0.8209595680236816},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7123095989227295},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5479245185852051},{"id":"https://openalex.org/C2776145449","wikidata":"https://www.wikidata.org/wiki/Q1706418","display_name":"Dextroamphetamine","level":4,"score":0.5021624565124512},{"id":"https://openalex.org/C40010229","wikidata":"https://www.wikidata.org/wiki/Q3184856","display_name":"Substance abuse","level":2,"score":0.499575138092041},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4765877425670624},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4550217092037201},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.4137396812438965},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.37868615984916687},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3011570870876312},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003913","descriptor_name":"Dextroamphetamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005059","descriptor_name":"Euphoria","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006439","descriptor_name":"Hemodynamics","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008774","descriptor_name":"Methylphenidate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011597","descriptor_name":"Psychomotor Performance","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012054","descriptor_name":"Reinforcement, Psychology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1177/026988110401800411","doi":"https://doi.org/10.1177/026988110401800411","is_oa":false,"landing_page_url":"https://doi.org/10.1177/026988110401800411","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},{"id":"doi:10.1177/0269881104047281","doi":"https://doi.org/10.1177/0269881104047281","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881104047281","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:15582920","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15582920","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of psychopharmacology (Oxford, England)","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6566591837","display_name":"ASSESSING ABUSE POTENTIAL IN HUMAN--CNS STIMULANTS","funder_award_id":"R01DA012665","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320309825","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":59,"referenced_works":["https://openalex.org/W47927121","https://openalex.org/W54728729","https://openalex.org/W58486305","https://openalex.org/W144979964","https://openalex.org/W1515487220","https://openalex.org/W1524004585","https://openalex.org/W1964511631","https://openalex.org/W1965284500","https://openalex.org/W1977718302","https://openalex.org/W1980789028","https://openalex.org/W1987802056","https://openalex.org/W1989314580","https://openalex.org/W1990410952","https://openalex.org/W1994762742","https://openalex.org/W1999468298","https://openalex.org/W2001884390","https://openalex.org/W2008032124","https://openalex.org/W2008442515","https://openalex.org/W2013568408","https://openalex.org/W2014162693","https://openalex.org/W2014663087","https://openalex.org/W2014786760","https://openalex.org/W2024076839","https://openalex.org/W2027185076","https://openalex.org/W2034145346","https://openalex.org/W2042996833","https://openalex.org/W2046083750","https://openalex.org/W2046349278","https://openalex.org/W2047423810","https://openalex.org/W2049405861","https://openalex.org/W2054984124","https://openalex.org/W2066951615","https://openalex.org/W2074689143","https://openalex.org/W2075581667","https://openalex.org/W2081596871","https://openalex.org/W2082927185","https://openalex.org/W2084376094","https://openalex.org/W2091960381","https://openalex.org/W2094206436","https://openalex.org/W2095217951","https://openalex.org/W2109159740","https://openalex.org/W2120219218","https://openalex.org/W2122026713","https://openalex.org/W2129785079","https://openalex.org/W2134268640","https://openalex.org/W2141225113","https://openalex.org/W2146838987","https://openalex.org/W2169755193","https://openalex.org/W2184365199","https://openalex.org/W2219079612","https://openalex.org/W2223273811","https://openalex.org/W2323042322","https://openalex.org/W2331368560","https://openalex.org/W2440716747","https://openalex.org/W2495649136","https://openalex.org/W2791114118","https://openalex.org/W4205533652","https://openalex.org/W4239393784","https://openalex.org/W4322694690"],"related_works":["https://openalex.org/W2033200028","https://openalex.org/W2323042322","https://openalex.org/W2002827980","https://openalex.org/W1999458463","https://openalex.org/W3044850122","https://openalex.org/W2094206436","https://openalex.org/W167078310","https://openalex.org/W2028338983","https://openalex.org/W2082927185","https://openalex.org/W7211877000"],"abstract_inverted_index":{"Methylphenidate":[0],"has":[1,168],"potential":[2,34],"for":[3,89],"abuse":[4,33,172],"because":[5],"it":[6],"produces":[7],"behavioural":[8],"effects":[9,74,101,145],"similar":[10],"to":[11,29,39,47],"those":[12],"observed":[13],"with":[14,92,156],"other":[15],"abused":[16],"stimulants,":[17],"such":[18],"as":[19],"d-amphetamine":[20,64,118,128],"and":[21,61,67,70,99,109,117,127,141,159],"cocaine.":[22],"The":[23,72,112],"aim":[24],"of":[25,35,54,75,115,146],"this":[26,50],"study":[27],"was":[28],"further":[30],"characterize":[31],"the":[32,107,144],"oral":[36,40],"methylphenidate":[37,58,116,126,167],"relative":[38],"d-amphetamine.":[41],"Ten":[42],"drug-abusing":[43],"volunteers":[44],"were":[45,78,102,149],"recruited":[46],"participate":[48],"in":[49,132],"study,":[51],"which":[52],"consisted":[53],"seven":[55],"dose":[56,114],"conditions:":[57],"(16,":[59],"32":[60],"48":[62],"mg),":[63],"(8,":[65],"16":[66],"24":[68],"mg)":[69],"placebo.":[71],"reinforcing":[73],"these":[76,147],"drugs":[77,148],"assessed":[79,103],"during":[80,105],"a":[81,86,93],"self-administration":[82,110],"session":[83,88],"(preceded":[84],"by":[85],"sampling":[87,108],"each":[90],"condition)":[91],"modified":[94],"progressive-ratio":[95],"procedure.":[96],"Subject-rated,":[97],"performance":[98],"physiological":[100],"concurrently":[104],"both":[106],"sessions.":[111],"intermediate":[113],"increased":[119],"responding":[120],"significantly":[121],"above":[122],"placebo":[123],"levels.":[124],"Both":[125],"produced":[129],"dose-dependent":[130],"increases":[131],"stimulant-like":[133],"subject":[134],"ratings":[135],"(e.g.":[136],"Active,":[137],"Alert,":[138],"or":[139],"Energetic":[140],"High),":[142],"but":[143],"not":[150],"isomorphic.":[151],"These":[152],"findings":[153,161],"are":[154],"consistent":[155],"epidemiological":[157],"data":[158],"previous":[160],"from":[162],"laboratory":[163],"studies":[164],"that":[165],"suggest":[166],"at":[169],"least":[170],"some":[171],"potential.":[173]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1978196659","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":4},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
